LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
RTSNCIK 0002002988

Retension Pharmaceuticals, Inc.

27 transactions by 7 insiders, from October 8, 2026 to October 13, 2026.

Transactions
277 insiders
Bought · P
$370Kopen market
Sold · S
Nonenobody sold on the open market
Net
+$370Knet buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Eric L. KellerCEO6—$250K—
Michael J. BerendtDir5———
Franklin M. BergerDir4—$120K—
Paul SweetnamChief4———
Sabine BissonCOO4———
Donald OldsDir3———
Pavan CheruvuDir1———

All transactions

27 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Eric L. KellerCEODERIVOct 13C31,368——
Eric L. KellerCEODERIVOct 13C9,662——
Eric L. KellerCEODERIVOct 13A255,174$0.00—?
Eric L. KellerCEOOct 13C31,368——
Eric L. KellerCEOOct 13C9,662——
Eric L. KellerCEOOct 13P20,800$12.00$250K
Paul SweetnamChiefDERIVOct 13C2,640——
Paul SweetnamChiefDERIVOct 13C4,026——
Paul SweetnamChiefOct 13C2,640——
Paul SweetnamChiefOct 13C4,026——
Donald OldsDirDERIVOct 13C5,637——
Donald OldsDirOct 13C5,637——
Pavan CheruvuDirDERIVOct 13A5,636$0.00—?
Sabine BissonCOODERIVOct 13C2,504——
Sabine BissonCOODERIVOct 13C1,611——
Sabine BissonCOOOct 13C2,504——
Sabine BissonCOOOct 13C1,611——
Franklin M. BergerDirDERIVOct 13C12,517——
Franklin M. BergerDirOct 13P10,000$12.00$120K
Franklin M. BergerDirOct 13C12,517——
Michael J. BerendtDirDERIVOct 13C2,640——
Michael J. BerendtDirDERIVOct 13C4,026——
Michael J. BerendtDirOct 13C2,640——
Michael J. BerendtDirOct 13C4,026——
Michael J. BerendtDirDERIVOct 8A5,636$0.00—?
Donald OldsDirDERIVOct 8A5,636$0.00—?
Franklin M. BergerDirDERIVOct 8A5,636$0.00—?